UnitedHealth Group (UNH) Price Target Raised to $285.00 at Argus

UnitedHealth Group (NYSE:UNH) had its target price increased by Argus to $285.00 in a report published on Thursday morning, The Fly reports. They currently have a buy rating on the healthcare conglomerate’s stock.

A number of other equities analysts also recently commented on UNH. Oppenheimer lifted their price objective on UnitedHealth Group from $276.00 to $295.00 and gave the stock an outperform rating in a research report on Wednesday. Cantor Fitzgerald reiterated a buy rating and set a $300.00 price objective on shares of UnitedHealth Group in a research report on Thursday, July 5th. BMO Capital Markets lifted their price objective on UnitedHealth Group from $285.00 to $300.00 and gave the stock a positive rating in a research report on Thursday, June 21st. Royal Bank of Canada lifted their price objective on UnitedHealth Group to $308.00 and gave the stock an outperform rating in a research report on Wednesday. Finally, Piper Jaffray Companies lifted their price objective on UnitedHealth Group to $300.00 and gave the stock an overweight rating in a research report on Wednesday. One analyst has rated the stock with a hold rating, twenty-three have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of Buy and an average price target of $289.41.

Shares of NYSE:UNH traded down $1.79 during trading on Thursday, reaching $265.02. The stock had a trading volume of 120,905 shares, compared to its average volume of 3,334,371. The company has a debt-to-equity ratio of 0.61, a current ratio of 0.69 and a quick ratio of 0.75. The firm has a market capitalization of $257.27 billion, a PE ratio of 26.52, a P/E/G ratio of 1.58 and a beta of 0.73. UnitedHealth Group has a 1-year low of $202.70 and a 1-year high of $272.81.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 16th. The healthcare conglomerate reported $3.41 EPS for the quarter, topping the Zacks’ consensus estimate of $3.30 by $0.11. UnitedHealth Group had a return on equity of 23.62% and a net margin of 5.71%. The firm had revenue of $56.56 billion for the quarter, compared to the consensus estimate of $56.34 billion. During the same quarter last year, the business posted $2.66 earnings per share. The firm’s revenue was up 12.4% compared to the same quarter last year. As a group, analysts expect that UnitedHealth Group will post 12.81 earnings per share for the current year.

In related news, EVP D Ellen Wilson sold 15,393 shares of the business’s stock in a transaction on Friday, August 24th. The stock was sold at an average price of $264.29, for a total value of $4,068,215.97. Following the sale, the executive vice president now owns 66,402 shares in the company, valued at approximately $17,549,384.58. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Steven H. Nelson sold 8,142 shares of the business’s stock in a transaction on Thursday, September 13th. The shares were sold at an average price of $265.00, for a total value of $2,157,630.00. Following the completion of the sale, the chief executive officer now owns 22,496 shares in the company, valued at approximately $5,961,440. The disclosure for this sale can be found here. Insiders sold 94,568 shares of company stock worth $24,950,027 in the last 90 days. Company insiders own 0.87% of the company’s stock.

Several hedge funds have recently bought and sold shares of UNH. Welch Group LLC purchased a new stake in shares of UnitedHealth Group in the 2nd quarter valued at $106,000. Blue Chip Partners Inc. purchased a new stake in shares of UnitedHealth Group in the 2nd quarter valued at $107,000. Northwest Wealth Management LLC purchased a new stake in shares of UnitedHealth Group in the 2nd quarter valued at $117,000. Fort L.P. purchased a new stake in shares of UnitedHealth Group in the 2nd quarter valued at $119,000. Finally, Polaris Greystone Financial Group LLC purchased a new stake in shares of UnitedHealth Group in the 3rd quarter valued at $120,000. Hedge funds and other institutional investors own 85.42% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Further Reading: Google Finance

The Fly

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply